查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813793

美國器官晶片市場：市場規模、佔有率、趨勢分析（按產品/服務、應用和最終用途）、細分市場預測（2025-2033）

U.S. Organ-on-a-Chip Market Size, Share & Trends Analysis Report By Product & Service, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國器官晶片市場概況

預計 2024 年美國器官晶片市值將達 7,170 萬美元，到 2033 年將達到 9.404 億美元，2025 年至 2033 年的複合年成長率為 33.14%。

這種成長的動力來自於對更具預測性的臨床前測試模型的需求不斷成長、動物測試的轉變以及微流體、組織工程和個人化醫療的快速發展。

隨著製藥公司、生物技術公司和研究機構尋求更準確、更合乎道德和更具成本效益的方法來研究人體生理和疾病，器官晶片技術作為生物醫學領域改變遊戲規則的解決方案正受到越來越多的關注。

微流體和組織工程的進展

微流體和組織工程的進步是美國器官晶片產業發展的基礎。微流體技術能夠在微觀尺度上精確控制營養素、藥物和機械刺激的流動，忠實地模擬人體的動態狀態。組織工程則對此進行了補充，利用人體衍生細胞創建3D細胞結構，這些細胞結構可以透過基因工程改造，在功能上類似於特定器官，例如肝臟、肺、心臟和腸道。這些技術進步顯著提高了臨床前試驗的生理相關性，為研究人員提供了更具預測性和倫理責任性的疾病和藥物反應研究工具。

幹細胞技術，尤其是誘導性多功能幹細胞(iPSC) 的整合，使得患者特異性模型的開發成為可能，進一步提升了器官移植平台 (OOC) 的價值。此類個人化晶片可以反映個體獨特的基因變異和疾病表現型，從而支持精準醫療。此外，近期的技術創新使得多個器官系統能夠連接在單一晶片上，使研究人員能夠研究藥物和疾病如何以非孤立的方式影響人體。工程學與生物學的這種融合正在推動製藥、生物技術和學術研究領域的持續需求。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章市場因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 產業分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章：依產品/服務進行的業務分析

  • 產品/服務細分儀表板
  • 美國器官晶片市場：產品與服務差異分析
  • 美國器官晶片市場規模與趨勢分析（按產品/服務，2021-2033 年）
  • 產品
    • 產品市場估計與預測（2021-2033）
    • 裝置
    • 美國的器官晶片設備
  • 服務
    • 服務市場估計與預測（2021-2033）

第5章 按應用程式進行的業務分析

  • 根據用途細分儀表板
  • 美國器官晶片市場：按應用進行的變化分析
  • 2021-2033年美國器官晶片市場規模及應用趨勢分析
  • 藥物研發
    • 藥物研發市場估計與預測（2021-2033）
  • 毒性分析
    • 毒理學分析市場估計與預測（2021-2033）
  • 其他
    • 其他市場估計與預測（2021-2033）

第6章 以最終用途分類的業務分析

  • 依最終用途細分儀表板
  • 美國器官晶片市場：按最終用途進行的變化分析
  • 美國器官晶片市場規模及趨勢分析（依最終用途），2021-2033
  • 製藥和生物技術公司
    • 製藥和生物技術市場估計和預測（2021-2033）
  • 學術研究機構
    • 學術研究機構市場估計與預測（2021-2033）
  • 其他
    • 其他市場估計與預測（2021-2033）

第7章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 企業市場分析（2024年）
  • 公司簡介/上市公司
    • Emulate, Inc.
    • MIMETAS BV
    • Valo Health
    • Quris Technologies LTD.（Nortis, Inc.）
    • AxoSim
    • BICO-THE BIO CONVERGENCE COMPANY
    • CN Bio Innovations Ltd
    • The Charles Stark Draper Laboratory, Inc.
    • SynVivo, Inc.
    • AlveoliX AG
Product Code: GVR-4-68040-695-2

U.S. Organ-on-a-Chip Market Summary

The U.S. organ-on-a-chip market size was estimated at USD 71.7 million in 2024 and is projected to reach USD 940.4 million by 2033, growing at a CAGR of 33.14% from 2025 to 2033. This growth is driven by increasing demand for more predictive preclinical testing models, a shift from animal testing, and rapid advancements in microfluidics, tissue engineering, and personalized medicine.

As pharmaceutical companies, biotech firms, and research institutions seek more accurate, ethical, and cost-effective ways to study human physiology and disease, organ-on-a-chip technologies are gaining traction as a transformative solution across the biomedical landscape.

Advancements in Microfluidics & Tissue Engineering

Advancements in microfluidics and tissue engineering have become a foundational driver of growth in the U.S. organ-on-a-chip industry. Microfluidic technologies enable precise control over the flow of nutrients, drugs, and mechanical stimuli at a microscale, closely mimicking the dynamic conditions of the human body. Tissue engineering complements this by enabling the creation of 3D cellular structures using human-derived cells, which can be designed to functionally resemble specific organs like the liver, lung, heart, or gut. These innovations have significantly improved the physiological relevance of preclinical testing, offering researchers more predictive and ethically responsible tools for studying disease and drug response.

The integration of stem cell technology, particularly induced pluripotent stem cells (iPSCs), further enhances the value of OOC platforms by allowing the development of patient-specific models. These personalized chips can reflect genetic variations and disease phenotypes unique to individuals, supporting precision medicine approaches. Moreover, recent innovations have allowed multiple organ systems to be connected on a single chip, enabling researchers to study how drugs or diseases affect the body rather than in isolation. This convergence of engineering and biology fuels sustained demand across the pharmaceutical, biotech, and academic research.

U.S. Organ-on-a-Chip Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. organ-on-a-chip market report based on the product & service, application, and end-use:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • Instrument
    • Devices
    • Liver-on-a-Chip
    • Lung-on-a-Chip
    • Intestine-on-a-Chip
    • Kidney-on-a-Chip
    • Heart-on-a-Chip
    • Others
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
  • Toxicology Research
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product & Service Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in microfluidics & tissue engineering
      • 3.2.1.2. Increasing demand for disease modeling technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Technical challenges and complexities associated with organ-on-a-chip technique
      • 3.2.2.2. Regulatory hurdles in organ-on-a-chip method
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product & Service Group Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. U.S. Organ-on-a-Chip Market Product & Service Movement Analysis
  • 4.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. U.S. Organ-on-a-Chip Devices
      • 4.4.3.1. Organ-on-a-chip devices market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Liver-on-a-Chip
        • 4.4.3.2.1. Liver-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Lung-on-a-Chip
        • 4.4.3.3.1. Lung-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Intestine-on-a-Chip
        • 4.4.3.4.1. Intestine-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.5. Kidney-on-a-Chip
        • 4.4.3.5.1. Kidney-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.6. Heart-on-a-Chip
        • 4.4.3.6.1. Heart-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.7. Others
        • 4.4.3.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Group Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Organ-on-a-Chip Market Application Movement Analysis
  • 5.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Toxicology Research
    • 5.5.1. Toxicology research market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. Organ-on-a-Chip Market End Use Movement Analysis
  • 6.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Academic & Research Institute
    • 6.5.1. Academic & research institute market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Emulate, Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. MIMETAS B.V.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Valo Health
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Quris Technologies LTD. (Nortis, Inc.)
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. AxoSim
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. BICO - THE BIO CONVERGENCE COMPANY
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. CN Bio Innovations Ltd
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. The Charles Stark Draper Laboratory, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. SynVivo, Inc.
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. AlveoliX AG
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. U.S. organ-on-a-chip market, by product & service, 2021 - 2033 (USD Million)
  • Table 3. U.S. organ-on-a-chip market, by application, 2021 - 2033 (USD Million)
  • Table 4. U.S. organ-on-a-chip market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. Organ-on-a-chip market: market outlook
  • Fig. 7 U.S. Organ-on-a-chip competitive Insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. Organ-on-a-chip market driver impact
  • Fig. 10 U.S. Organ-on-a-chip market restraint impact
  • Fig. 11 U.S. Organ-on-a-chip market: Products & service movement analysis
  • Fig. 12 U.S. Organ-on-a-chip market: Products & service outlook and key takeaways
  • Fig. 13 Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Organ-on-a-chip devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Liver-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Lung-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Intestine-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Kidney-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Heart-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Organ-on-a-chip market: Application movement analysis
  • Fig. 24 U.S. Organ-on-a-chip market: Application outlook and key takeaways
  • Fig. 25 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Toxicology research market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Organ-on-a-chip market: End use movement analysis
  • Fig. 29 U.S. Organ-on-a-chip market: End use outlook and key takeaways
  • Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Academic & research institute market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2021 - 2033 (USD Million)